DIN 02529556 — TEZSPIRE 110 MG
TEZSPIRE is a solution of Tezepelumab marketed by ASTRAZENECA CANADA INC. The full Tezepelumab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02529556
- Brand name
- TEZSPIRE
- Active ingredient
- Tezepelumab
- Strength
- 110 MG
- Dosage form
- SOLUTION
- Route
- SUBCUTANEOUS
- Manufacturer
- ASTRAZENECA CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Anti-TSLP human monoclonal antibody (biologic respiratory therapy)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Tezepelumab products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02529548 | TEZSPIRE | 110 MG | SOLUTION | ASTRAZENECA CANADA INC | MARKETED |